These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15246224)

  • 1. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment.
    Vallet-Pichard A; Pol S
    J Hepatol; 2004 Jul; 41(1):156-66. PubMed ID: 15246224
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of BHIVA guidelines for HIV and hepatitis B or C co-infection.
    Brook MG
    J HIV Ther; 2003 Nov; 8(4):85-8. PubMed ID: 14671505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
    Dervisevic S; Pillay D
    J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
    Alberti A; Clumeck N; Collins S; Gerlich W; Lundgren J; Palù G; Reiss P; Thiebaut R; Weiland O; Yazdanpanah Y; Zeuzem S;
    J Hepatol; 2005 May; 42(5):615-24. PubMed ID: 15916745
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
    Goedert JJ;
    Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of advanced HIV disease in patients with tuberculosis or hepatitis co-infection.
    Nelson M; Lipman M
    Int J Clin Pract; 2006 Aug; 60(8):976-83. PubMed ID: 16893439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline watch. New guidelines on treating chronic hepatitis B and C in HIV-coinfected patients.
    Gandhi RT
    AIDS Clin Care; 2005 Jul; 17(7):65. PubMed ID: 16110574
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for managing coinfection with hepatitis B virus and HIV.
    Sherman M
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S30-3. PubMed ID: 19465707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
    Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges].
    Laufer NL; Quarleri JF; Bouzas MB; Perez HM; Salomon H; Cahn PE
    Medicina (B Aires); 2007; 67(1):82-91. PubMed ID: 17408028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/hepatitis C virus and HIV/hepatitis B virus coinfections protect against antiretroviral-related hyperlipidaemia.
    Diong C; Raboud J; Li M; Cooper C;
    HIV Med; 2011 Aug; 12(7):403-11. PubMed ID: 21244600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K; Ringland C;
    HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is hepatitis virus resistance to antiviral drugs a threat?
    Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
    Cheruvu S; Marks K; Talal AH
    Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference.
    Salmon D; Robain M; Rockstroh JK; Benhamou Y
    J Hepatol; 2006; 44(1 Suppl):S2-5. PubMed ID: 16360970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa.
    Cooper CL; Mills E; Wabwire BO; Ford N; Olupot-Olupot P
    Int J Infect Dis; 2009 May; 13(3):302-6. PubMed ID: 19004656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.